PCR-based zebrafish model for personalised medicine in head and neck cancer.
Ahmed Al-SamadiKatja TuomainenAnne KivimäkiAbdelhakim SalemSakhr Al-KubatiAini HyytiäinenMataleena ParikkaKarri MesimäkiTommy WilkmanAntti MäkitieReidar GrenmanTuula SaloPublished in: Journal of translational medicine (2019)
We introduce a novel, easy, fast and cost-effective PCR-based in vivo zebrafish larvae assay to test the response of cell lines and clinical tumour samples to anti-cancer drugs. This method goes hand-by-hand with the commonly used imaging assay.